Copyright Reports & Markets. All rights reserved.

Global Insulin API Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Request for Sample of this report
Buy now

Table of Contents

    1 Market Overview

    • 1.1 Insulin API Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Regular Human Insulin
      • 1.2.2 Insulin Analogue
    • 1.3 Market Analysis by Applications
      • 1.3.1 Fast-acting
      • 1.3.2 Premix
      • 1.3.3 Long-acting
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 Novo Nordisk
      • 2.1.1 Business Overview
      • 2.1.2 Insulin API Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 Novo Nordisk Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi-Aventis
      • 2.2.1 Business Overview
      • 2.2.2 Insulin API Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi-Aventis Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 Eli Lilly
      • 2.3.1 Business Overview
      • 2.3.2 Insulin API Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 Eli Lilly Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Tonghua Dongbao
      • 2.4.1 Business Overview
      • 2.4.2 Insulin API Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Tonghua Dongbao Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 United Laboratory
      • 2.5.1 Business Overview
      • 2.5.2 Insulin API Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 United Laboratory Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Biocon
      • 2.6.1 Business Overview
      • 2.6.2 Insulin API Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Biocon Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Torrent Pharma
      • 2.7.1 Business Overview
      • 2.7.2 Insulin API Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Torrent Pharma Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Amphastar
      • 2.8.1 Business Overview
      • 2.8.2 Insulin API Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Amphastar Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 Ganlee
      • 2.9.1 Business Overview
      • 2.9.2 Insulin API Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 Ganlee Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Julphar Diabetes
      • 2.10.1 Business Overview
      • 2.10.2 Insulin API Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Julphar Diabetes Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 Wockhardt
      • 2.11.1 Business Overview
      • 2.11.2 Insulin API Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 Wockhardt Insulin API Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Insulin API Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Insulin API Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Insulin API Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Insulin API Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Insulin API Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Insulin API Market Analysis by Regions

    • 4.1 Global Insulin API Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Insulin API Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Insulin API Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Insulin API Sales and Growth Rate (2014-2019)
    • 4.3 Europe Insulin API Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Insulin API Sales and Growth Rate (2014-2019)
    • 4.5 South America Insulin API Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Insulin API Sales and Growth Rate (2014-2019)

    5 North America Insulin API by Country

    • 5.1 North America Insulin API Sales, Revenue and Market Share by Country
      • 5.1.1 North America Insulin API Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Insulin API Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Insulin API Sales and Growth Rate (2014-2019)
    • 5.3 Canada Insulin API Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Insulin API Sales and Growth Rate (2014-2019)

    6 Europe Insulin API by Country

    • 6.1 Europe Insulin API Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Insulin API Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Insulin API Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Insulin API Sales and Growth Rate (2014-2019)
    • 6.3 UK Insulin API Sales and Growth Rate (2014-2019)
    • 6.4 France Insulin API Sales and Growth Rate (2014-2019)
    • 6.5 Russia Insulin API Sales and Growth Rate (2014-2019)
    • 6.6 Italy Insulin API Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Insulin API by Country

    • 7.1 Asia-Pacific Insulin API Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Insulin API Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Insulin API Revenue and Market Share by Country (2014-2019)
    • 7.2 China Insulin API Sales and Growth Rate (2014-2019)
    • 7.3 Japan Insulin API Sales and Growth Rate (2014-2019)
    • 7.4 Korea Insulin API Sales and Growth Rate (2014-2019)
    • 7.5 India Insulin API Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Insulin API Sales and Growth Rate (2014-2019)

    8 South America Insulin API by Country

    • 8.1 South America Insulin API Sales, Revenue and Market Share by Country
      • 8.1.1 South America Insulin API Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Insulin API Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Insulin API Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Insulin API Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Insulin API Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Insulin API by Countries

    • 9.1 Middle East and Africa Insulin API Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Insulin API Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Insulin API Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Insulin API Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Insulin API Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Insulin API Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Insulin API Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Insulin API Sales and Growth Rate (2014-2019)

    10 Global Insulin API Market Segment by Type

    • 10.1 Global Insulin API Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Insulin API Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Insulin API Revenue and Market Share by Type (2014-2019)
    • 10.2 Regular Human Insulin Sales Growth and Price
      • 10.2.1 Global Regular Human Insulin Sales Growth (2014-2019)
      • 10.2.2 Global Regular Human Insulin Price (2014-2019)
    • 10.3 Insulin Analogue Sales Growth and Price
      • 10.3.1 Global Insulin Analogue Sales Growth (2014-2019)
      • 10.3.2 Global Insulin Analogue Price (2014-2019)

    11 Global Insulin API Market Segment by Application

    • 11.1 Global Insulin API Sales Market Share by Application (2014-2019)
    • 11.2 Fast-acting Sales Growth (2014-2019)
    • 11.3 Premix Sales Growth (2014-2019)
    • 11.4 Long-acting Sales Growth (2014-2019)

    12 Insulin API Market Forecast (2019-2024)

    • 12.1 Global Insulin API Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Insulin API Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Insulin API Market Forecast (2019-2024)
      • 12.2.2 Europe Insulin API Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Insulin API Market Forecast (2019-2024)
      • 12.2.4 South America Insulin API Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Insulin API Market Forecast (2019-2024)
    • 12.3 Insulin API Market Forecast by Type (2019-2024)
      • 12.3.1 Global Insulin API Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Insulin API Market Share Forecast by Type (2019-2024)
    • 12.4 Insulin API Market Forecast by Application (2019-2024)
      • 12.4.1 Global Insulin API Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Insulin API Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Insulin is used to treat type 1 diabetes (condition in which the body does not produce insulin and therefore cannot control the amount of sugar in the blood). It is also used to treat people with type 2 diabetes (condition in which the body does not use insulin normally and, therefore, cannot control the amount of sugar in blood) who need insulin to control their diabetes. Nowadays, Insulin as an important drug is widely used to treat diabetes.
      In China and Chinese insulin market, animal insulin, called first generation insulin, has been almost replaced by new type generation insulin. Basing on the trend of China and Chinese insulin industry, this report researches the market of human insulin and insulin analogue in China.
      In this report, the statistics of insulin industry is based on Insulin API, the physical features of insulin API is Freeze-dried powder. The weight unite of insulin API weight is Kg in this report.

      Scope of the Report:
      Insulin API is a relatively concentrated industry in China, The main production are concentrated in Novo Nordisk, Eli Lilly, Sanofi several companies but their products are for their own use. Gan Lee Tonghua Dongbao in recent years to expand production capacity, and they are the main providers of insulin API
      The overall domestic policy for the development of insulin API is supported. Local governments have a lot of policies to support the development of the industry. But in recent years environmental protection requirements for the fermentation industry are also getting higher and higher.
      The worldwide market for Insulin API is expected to grow at a CAGR of roughly 4.2% over the next five years, will reach 2120 million US$ in 2024, from 1660 million US$ in 2019, according to a new GIR (Global Info Research) study.
      This report focuses on the Insulin API in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Market Segment by Manufacturers, this report covers
      Novo Nordisk
      Sanofi-Aventis
      Eli Lilly
      Tonghua Dongbao
      United Laboratory
      Biocon
      Torrent Pharma
      Amphastar
      Ganlee
      Julphar Diabetes
      Wockhardt

      Market Segment by Regions, regional analysis covers
      North America (United States, Canada and Mexico)
      Europe (Germany, France, UK, Russia and Italy)
      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
      South America (Brazil, Argentina, Colombia etc.)
      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers
      Regular Human Insulin
      Insulin Analogue

      Market Segment by Applications, can be divided into
      Fast-acting
      Premix
      Long-acting

      The content of the study subjects, includes a total of 15 chapters:
      Chapter 1, to describe Insulin API product scope, market overview, market opportunities, market driving force and market risks.
      Chapter 2, to profile the top manufacturers of Insulin API, with price, sales, revenue and global market share of Insulin API in 2017 and 2018.
      Chapter 3, the Insulin API competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
      Chapter 4, the Insulin API breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
      Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
      Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
      Chapter 12, Insulin API market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
      Chapter 13, 14 and 15, to describe Insulin API sales channel, distributors, customers, research findings and conclusion, appendix and data source.

      Buy now